EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹681 Cr | ₹498 Cr | ₹532 Cr | ₹662 Cr | ₹392 Cr |
What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹681 Cr |
| Mar2024 | ₹498 Cr |
| Mar2023 | ₹532 Cr |
| Mar2022 | ₹662 Cr |
| Mar2021 | ₹392 Cr |
How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹681 Cr | 36.76 | |
| Mar2024 | ₹498 Cr | -6.36 | |
| Mar2023 | ₹532 Cr | -19.66 | |
| Mar2022 | ₹662 Cr | 68.87 | |
| Mar2021 | ₹392 Cr | - | |
Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹27,190.5 Cr | -2.5% | -5.7% | 49.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -2.5% |
-5.7% |
49.9% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses